B.Sc. with Honors in Biology - 1975,University in California
Ph.D. in Neuroscience - 1980,University in British Columbia, Canada
Synthelabo L.E.R.S. Paris, France (1980 - 1982)
School of Medicine in Maryland, Department of Psychiatry,(1982 - 1983)
President, Pharmaceutical Consulting Company in Pennsylvania (2001 - present)
Adjunct Associate Professor, University in Canada (2000 - 2002)
Director, Dept Retinal Research Bio-Science Firm in California(1999 - 2001)
CEO of Pharmaceutical Company in Canada (1999 - 2000)
CEO of Bio-Technology Company in Pennsylvania (1995 - 1998)
University in Pennsylvania USA
Department of Neurosurgery (1993 - 1999)
Department of Mental Health Sciences (1990 - 1993)
Associate Professor (1990 - 1999)
Project Leader in Drug Discovery, France, Neurobiology Division (1988 - 1990)
Chef de Projet (1989 - 1990)
Cadre en Recherche Pharmacologique (1988 - 1989)
Corporation in New Jersey
Department of Neuroscience/Cardiovascular Research (1983 - 1988)
Senior Research Scientist (1985 - 1988)
NMDA Project Leader (1983 - 1987)
Senior Scientist (1983 - 1985)
School of Medicine in Maryland, Department of Neurology (1984 - 1987)
Adjunct Assistant Professor (1984 - 1987)
Society of Toxicology
RTC Roundtable of Toxicology Consultant
Available upon request
Phen-Fen Expert Witness, fenfluramine Expert Witness, Viagra Expert Witness, sildenafil Expert Witness, FDA Expert Witness, Food and Drug Administration Expert Witness, pharmaceutical Expert Witness, pharmacology Expert Witness, bioscience Expert Witness, retinal research Expert Witness, neurosurgery Expert Witness, mental health sciences Expert Witness